Cilostazol Suppresses Aβ-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cilostazol Suppresses Aβ-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-10-17
DOI
10.3389/fnagi.2017.00337
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative and Nitrosative Modifications of Biliverdin Reductase-A in the Brain of Subjects with Alzheimer's Disease and Amnestic Mild Cognitive Impairment
- (2018) Eugenio Barone et al. JOURNAL OF ALZHEIMERS DISEASE
- Apoptosis and Oxidative Stress in Neurodegenerative Diseases
- (2018) Elena Radi et al. JOURNAL OF ALZHEIMERS DISEASE
- Compromised MAPK signaling in human diseases: an update
- (2015) Eun Kyung Kim et al. ARCHIVES OF TOXICOLOGY
- Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia
- (2015) Hideo Shichinohe et al. BRAIN RESEARCH
- Protective Effects of Baicalin on Aβ1–42-Induced Learning and Memory Deficit, Oxidative Stress, and Apoptosis in Rat
- (2015) Haitao Ding et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis
- (2014) LiGen Shi et al. BMC Neurology
- Combining Valosin-containing Protein (VCP) Inhibition and Suberanilohydroxamic Acid (SAHA) Treatment Additively Enhances the Folding, Trafficking, and Function of Epilepsy-associated γ-Aminobutyric Acid, Type A (GABAA) Receptors
- (2014) Dong-Yun Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid
- (2014) Takakuni Maki et al. Annals of Clinical and Translational Neurology
- Peripheral expression of MAPK pathways in Alzheimer’s and Parkinson’s diseases
- (2013) Shan Wang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Recent Studies of Antioxidant Quinoline Derivatives
- (2013) M. Orhan Puskullu et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Ginsenoside Rb1 Attenuates Oxygen-Glucose Deprivation-Induced Apoptosis in SH-SY5Y Cells via Protection of Mitochondria and Inhibition of AIF and Cytochrome c Release
- (2013) Jianmin Liang et al. MOLECULES
- Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment
- (2012) Eugenio Barone et al. FREE RADICAL BIOLOGY AND MEDICINE
- Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons
- (2011) Subbiah Pugazhenthi et al. Molecular Neurodegeneration
- Cognitive impairment in humanized APP×PS1 mice is linked to Aβ1–42 and NOX activation
- (2011) Annadora J. Bruce-Keller et al. NEUROBIOLOGY OF DISEASE
- Pathological roles of MAPK signaling pathways in human diseases
- (2010) Eun Kyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cilostazol prevents amyloid β peptide25-35-induced memory impairment and oxidative stress in mice
- (2010) Masayuki Hiramatsu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events
- (2010) Graeme J Hankey et al. LANCET NEUROLOGY
- Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
- (2010) Viktor Lakics et al. NEUROPHARMACOLOGY
- ERK and cell death: ERK1/2 in neuronal death
- (2009) Srinivasa Subramaniam et al. FEBS Journal
- ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
- (2009) Sebastien Cagnol et al. FEBS Journal
- Cilostazol Attenuates 4-hydroxynonenal-enhanced CD36 Expression on Murine Macrophages via Inhibition of NADPH Oxidase-derived Reactive Oxygen Species Production
- (2009) Mi Ran Yun et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Oligomeric aggregates of amyloid β peptide 1–42 activate ERK/MAPK in SH-SY5Y cells via the α7 nicotinic receptor
- (2009) Kirk F. Young et al. NEUROCHEMISTRY INTERNATIONAL
- Phosphorylated tau in neuritic plaques of APPsw/Tauvlw transgenic mice and Alzheimer disease
- (2008) Mar Pérez et al. ACTA NEUROPATHOLOGICA
- Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes
- (2008) K. Suzuki et al. AMERICAN JOURNAL OF HYPERTENSION
- JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1
- (2008) Elena Tamagno et al. NEUROBIOLOGY OF AGING
- Microtubule-associated protein tau in development, degeneration and protection of neurons
- (2008) Jian-Zhi Wang et al. PROGRESS IN NEUROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started